Correction of the molecular phenotype of X-linked Dystonia-Parkinsonism reveals a non-canonical function of BRD4
Open Access
- 5 May 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Transcription and mRNA processing are tightly coupled regulatory layers on gene expression, and their perturbations underly human disorders. X-linked Dystonia-Parkinsonism (XDP) is a unique example of a human disease connecting aberrant mRNA processing and the basal transcription machinery. XDP is a rare, monogenic fatal neurodegenerative disorder, and a limited understanding of the underlying molecular mechanisms hinders the development of effective therapies. In this study, we show that depletion of BRD4, a chromatin reader known for its role in transcriptional pausing, rescues the XDP molecular signature. Unexpectedly, this effect is independent of the canonical coactivator role of BRD4. We demonstrate that the XDP-SVA induces intronic premature cleavage and polyadenylation within the TAF1 locus, and that BRD4 depletion bypasses this premature termination checkpoint. These findings reveal new dimensions of BRD4 activity beyond transcription pause release and suggest modulation of mRNA processing as a therapeutic strategy for XDP.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB992 Project number A07; TI688/1-1)
This publication has 40 references indexed in Scilit:
- A hexamer tandem repeat RNA embedded within an SVA retrotransposon drives R-loop formation and neurodegenerationCell Reports, 2025
- Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain–containing factorsCurrent Opinion in Genetics & Development, 2024
- A BRD4-mediated elongation control point primes transcribing RNA polymerase II for 3′-processing and terminationMolecular Cell, 2021
- Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-ParkinsonismJournal of Neural Transmission, 2021
- Neuroimaging and neuropathology studies of X-linked dystonia parkinsonismNeurobiology of Disease, 2021
- TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X‐linked Dystonia‐ParkinsonismMovement Disorders, 2020
- R-loop generation during transcription: Formation, processing and cellular outcomesDNA Repair, 2018
- Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome AssemblyCell, 2018
- BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 RecruitmentMolecular Cell, 2017
- Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4Molecular Cell, 2005